據安迅思倫敦5月31日消息，朗盛公司和Advent公司周二表示，兩家公司將收購荷蘭專用化學品公司帝斯曼旗下工程材料部門，并打算將該部門與朗盛自己的高性能材料業務合并。

在帝斯曼宣布計劃與總部位于瑞士的香精香料公司Firmenich合并數小時后，這家荷蘭公司同意出售其工程材料業務，標志著該公司最終轉型為一家健康、營養和生物科學專業公司。

Advent將支付約37億歐元收購帝斯曼工程材料業務。帝斯曼工程材料業務將與朗盛公司旗下高性能材料業務合并成立一家合資公司，總部位于美國的私人股本公司Advent將成為合資公司的控股股東。

兩家公司表示，Advent將向朗盛額外支付11億歐元，朗盛公司將在合資公司中持有約40%的股份。

這筆交易預計將于2023年上半年完成，合并后的帝斯曼/朗盛業務預計將實現約30億歐元的年銷售額。

龐曉華 摘譯自 ICIS

原文如下：

LANXESS, Advent to acquire DSM engineering materials arm, establish joint 

LANXESS and Advent are to acquire the engineering materials division of Netherlands-based specialties player DSM, the companies said on Tuesday, with an eye to merging the operations with LANXESS’ own high-performance materials business.

Coming hours after an announcement by DSM of plans to merge with Switzerland-based flavours and fragrances player Firmenich, the Dutch company agreed to sell its engineering materials business, signalling its final transformation into a health, nutrition, and biosciences specialist.

Advent is to pay around 3.7bn for the DSM business, which is to be folded into a joint venture with LANXESS high-performance materials business, with the US-headquartered private equity firm to stand as the majority owner of the combined operations.

Advent is to pay out an additional 1.1bn to LANXESS, with the Germany-based chemicals business to hold a stake of around 40% in the joint venture, the companies said.

The deal is expected to close in the first half of 2023, with the combined DSM/LANXESS business expected to have combined annual sales of around 3bn.